Latest WHO Guidelines for Rabies Post-Exposure Prophylaxis (PEP)
The latest WHO recommendation for rabies post-exposure prophylaxis is a 4-dose vaccine schedule administered on days 0,3,7, and 14, along with rabies immunoglobulin infiltrated around the wound for previously unvaccinated individuals. 1
Components of Rabies Post-Exposure Prophylaxis
Wound Treatment
- Immediate and thorough cleansing of all bite wounds and scratches with soap and water for 15 minutes is the first critical step in rabies prevention 1, 2
- If available, a virucidal agent such as povidone-iodine solution should be used to irrigate the wounds 1
- Wound cleansing alone has been shown to markedly reduce the likelihood of rabies in animal studies 1
- Suturing should be avoided when possible to prevent deeper inoculation of the virus 1
Rabies Immunoglobulin (RIG)
- Human Rabies Immunoglobulin (HRIG) is administered only once at the beginning of PEP to previously unvaccinated persons 1
- The recommended dose is 20 IU/kg body weight 1, 3
- If anatomically feasible, the full dose should be infiltrated around and into all wounds 1
- Any remaining volume should be administered intramuscularly at a site distant from vaccine administration 1
- HRIG can be administered up to day 7 after the first vaccine dose if not given initially 1
- HRIG should never be administered in the same syringe or at the same anatomical site as the first vaccine dose 1
- The WHO now emphasizes that local wound infiltration of RIG is the primary mechanism of protection 4
Vaccination Schedule
For previously unvaccinated individuals:
For previously vaccinated individuals:
Administration Considerations
- Vaccine should be administered in the deltoid area for adults and older children 1
- For younger children, the anterolateral aspect of the thigh may be used 1
- The gluteal area should never be used for vaccine administration due to risk of reduced immunogenicity 1, 3
- All PEP should begin as soon as possible after exposure, regardless of the time interval between exposure and initiation of treatment 1
Efficacy and Safety
- The 4-dose vaccine schedule has been proven safe and effective in inducing an adequate antibody response in all recipients 5
- Clinical trials with PCECV have demonstrated immunogenicity equivalent to HDCV 1
- Studies have shown that even 3 doses of rabies vaccine (days 0,3, and 7) can provide sufficient neutralizing antibody levels 6
- The intradermal 1-week vaccination regimen recommended by WHO carries important cost-, dose- and time-sparing benefits compared to older regimens 2
Special Considerations
- For pregnant women, rabies PEP should be administered as indicated, as the vaccine is safe and effective during pregnancy 7
- Postexposure prophylaxis should be initiated regardless of the length of delay since exposure, provided clinical signs of rabies are not present 1
- If the exposing animal is proven not to be rabid through appropriate laboratory testing, PEP can be discontinued 1
Common Pitfalls to Avoid
- Failure to adequately infiltrate wounds with HRIG, which is the primary mechanism of protection 4
- Administering vaccine in the gluteal area, which can result in diminished immune response 1
- Delaying PEP due to uncertainty about exposure - when in doubt, initiate treatment 3
- Not completing the full vaccination schedule, which is essential for adequate protection 2
- Inadequate wound cleansing, which is a critical first step in preventing rabies 1
The 4-dose vaccine schedule represents an evolution from previous 5-dose recommendations, offering similar protection with reduced healthcare visits, improved patient compliance, and lower costs 1, 5.